We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
-0.12%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$128M
(+7.8%)
Cap. Flow
+$150M
Cap. Flow
% of AUM
8.47%
Top 10 Holdings %
Top 10 Hldgs %
57.1%
Holding
53
New
17
Increased
12
Reduced
9
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$151M |
| 2 |
Intuitive Surgical
ISRG
|
+$116M |
| 3 |
AET
Aetna Inc
AET
|
+$100M |
| 4 |
Quest Diagnostics
DGX
|
+$83.3M |
| 5 |
Danaher
DHR
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$117M |
| 2 |
Edwards Lifesciences
EW
|
+$109M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$77.1M |
| 4 |
Cigna
CI
|
+$74.6M |
| 5 |
Eli Lilly
LLY
|
+$66.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.84% |
| 2 | Financials | 5.88% |
| 3 | Consumer Staples | 3.88% |
| 4 | Materials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
26
DELISTED
Hologic
HOLX
| $18.1M | 1.03% |
452,340
-1,447,660
| -76% | -$55.9M |
|
|
PRAH
27
DELISTED
PRA Health Sciences, Inc.
PRAH
| $16.5M | 0.93% |
300,000
-375,000
| -56% | -$20.6M |
|
28
Medpace
MEDP
$16.1B
| $15.3M | 0.87% |
425,000
+98,315
| +30% | +$3.27M |
|
|
CVRS
29
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $14M | 0.79% |
19,981,655
| – | – |
|
30
Thermo Fisher Scientific
TMO
$214B
| $13.4M | 0.76% |
+94,980
| New | +$14M |
|
|
MON
31
DELISTED
Monsanto Co
MON
| $13.2M | 0.74% |
+125,000
| New | +$12.8M |
|
32
Baxter International
BAX
$13.8B
| $13M | 0.74% |
+293,650
| New | +$13.6M |
|
33
HCA Healthcare
HCA
$85.7B
| $11.6M | 0.66% |
157,260
+67,520
| +75% | +$5.06M |
|
34
Globus Medical
GMED
$10.9B
| $11.2M | 0.63% |
+450,000
| New | +$10.2M |
|
35
Align Technology
ALGN
$12.4B
| $9.83M | 0.56% |
+102,263
| New | +$9.5M |
|
|
SPNE
36
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.07M | 0.29% |
641,700
+9,600
| +2% | +$81K |
|
37
Natera
NTRA
$38.6B
| $3.5M | 0.2% |
299,300
+4,500
| +2% | +$49.5K |
|
|
FOLD
38
CALL
DELISTED
Amicus Therapeutics
FOLD
| $2.48M | 0.14% |
+500,000
| New | +$3.46M |
|
39
Revvity
RVTY
$12.7B
| $2.3M | 0.13% |
+44,150
| New | +$2.31M |
|
40
Arbutus Biopharma
ABUS
$871M
| – | – |
-2,000,000
| Closed | -$6.88M |
|
41
Acadia Healthcare
ACHC
$2.62B
| – | – |
-770,000
| Closed | -$38.2M |
|
42
AMN Healthcare
AMN
$1.35B
| – | – |
-132,481
| Closed | -$4.22M |
|
|
43
CALL
Biogen
BIIB
$30.7B
| – | – |
-100,000
| Closed | -$31.3M |
|
|
44
Biogen
BIIB
$30.7B
| – | – |
-375,000
| Closed | -$117M |
|
45
Cardinal Health
CAH
$53.2B
| – | – |
-525,000
| Closed | -$40.8M |
|
|
46
Edwards Lifesciences
EW
$50B
| – | – |
-2,700,000
| Closed | -$109M |
|
|
47
Eli Lilly
LLY
$1.03T
| – | – |
-825,000
| Closed | -$66.2M |
|
48
Perrigo
PRGO
$1.43B
| – | – |
-197,300
| Closed | -$18.2M |
|
|
VAR
49
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-114,038
| Closed | -$9.95M |
|
|
MNK
50
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-875,000
| Closed | -$61.1M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q4 2016 Portfolio in Review
As of Q4 2016, HealthCor Management held 53 positions worth $1.77B, up 7.8% from $1.64B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
HealthCor Management deployed $150M of net new capital in Q4 2016, opening 17 new positions and adding to 12 existing holdings. Its largest new stake was Intuitive Surgical: 1,575,000 shares worth $111M.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 88% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Cigna, an estimated $74.6M trimmed.
- HealthCor Management's largest Q4 2016 buy was Intuitive Surgical: 1,575,000 shares worth $111M.
- HealthCor Management added most to Celgene Corp in Q4 2016, an estimated $151M increase.
- HealthCor Management's biggest Q4 2016 reduction was Cigna, cutting an estimated $74.6M.
- HealthCor Management fully exited Biogen in Q4 2016, selling an estimated $117M.
- HealthCor Management's ten largest holdings make up 57% of its $1.77B portfolio in Q4 2016.
- HealthCor Management opened 17 new positions and closed 14 in Q4 2016.
- HealthCor Management's portfolio value rose 7.8% quarter-over-quarter to $1.77B.
Based on HealthCor Management's 13F filing for Q4 2016, filed 14 Feb 2017.